Details

Cytokine-armed pyroptosis induces antitumor immunity against diverse types of tumors
ID Orehek, Sara (Author), ID Železnik Ramuta, Taja (Author), ID Lainšček, Duško (Author), ID Malenšek, Špela (Author), ID Šala, Martin (Author), ID Benčina, Mojca (Author), ID Jerala, Roman (Author), ID Hafner Bratkovič, Iva (Author)

.pdfPDF - Presentation file, Download (4,47 MB)
MD5: F7BD5C5E6975C448294CBB2AB699BB0C
URLURL - Source URL, Visit https://www.nature.com/articles/s41467-024-55083-3 This link opens in a new window

Abstract
Inflammasomes are defense complexes that utilize cytokines and immunogenic cell death (ICD) to stimulate the immune system against pathogens. Inspired by their dual action, we present cytokine-armed pyroptosis as a strategy for boosting immune response against diverse types of tumors. To induce pyroptosis, we utilize designed tightly regulated gasdermin D variants comprising different pore-forming capabilities and diverse modes of activation, representing a toolbox of ICD inducers. We demonstrate that the electrogenic transfer of ICD effector-encoding plasmids into mouse melanoma tumors when combined with intratumoral expression of cytokines IL-1β, IL-12, or IL-18, enhanced anti-tumor immune responses. Careful selection of immunostimulatory molecules is, however, imperative as a combination of IL-1β and IL-18 antagonized the protective effect of pyroptosis by IFNγ-mediated upregulation of several immunosuppressive pathways. Additionally, we show that the intratumoral introduction of armed pyroptosis provides protection against distant tumors and proves effective across various tumor types without inducing systemic inflammation. Deconstructed inflammasomes thus serve as a powerful, tunable, and tumor-agnostic strategy to enhance antitumor response, even against the most resilient types of tumors.

Language:English
Keywords:cancer immunotherapy, NOD-like receptors
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
BF - Biotechnical Faculty
Publication status:Published
Publication version:Version of Record
Year:2024
Number of pages:22 str.
Numbering:Vol. 15, art. 10801
PID:20.500.12556/RUL-176027 This link opens in a new window
UDC:577
ISSN on article:2041-1723
DOI:10.1038/s41467-024-55083-3 This link opens in a new window
COBISS.SI-ID:221013763 This link opens in a new window
Publication date in RUL:18.11.2025
Views:92
Downloads:23
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Nature communications
Shortened title:Nat. commun.
Publisher:Springer Nature
ISSN:2041-1723
COBISS.SI-ID:2315876 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:biokemija, imunski odziv, tumorji, inflamasomi

Projects

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-1746
Name:Vloga celične smrti v različnih aktivacijskih poteh inflamasoma NLRP3 in njena uporaba za inovativno imunoterapijo raka

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:N3-0358
Name:Celični stimulator: razvoj inovativne imunostimulatorne platforme

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:Z3-4501
Name:Sprožitev imunogene celične smrti z DNA senzorskim sistemom, ki prepozna genomski podpis, značilen za rakave celice

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:N1-0377
Name:Dizajn, mehanska stabilnost in uporaba modularnih proteinov na osnovi obvitih vijačnic

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-4640
Name:Inovativna imunoterapija raka preko CAR T celic (CARRS)

Funder:ARIS - Slovenian Research and Innovation Agency
Funding programme:Young researchers

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P4-0176
Name:Sintezna biologija in imunologija

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P1-0034
Name:Analitika in kemijska karakterizacija materialov ter procesov

Funder:EC - European Commission
Project number:101059842
Name:Centre of Excellence for the Technologies of Gene and Cell Therapy
Acronym:CTGCT

Funder:European Federation of Immunological Societies
Funding programme:Eastern Star Award

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back